2022
DOI: 10.1016/j.tiv.2022.105379
|View full text |Cite
|
Sign up to set email alerts
|

Comparative study of the percutaneous permeation and bioaccumulation of a cyclic siloxane using frozen-thawed and nonfrozen ex vivo human skin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 31 publications
0
3
0
Order By: Relevance
“…We demonstrated in our team’s earlier work [ 47 ] that the freezing process has no impact on the skin’s barrier properties; therefore, the use of frozen–thawed samples of the biological material did not affect the results of this research. The integrity of the skin samples’ barrier was confirmed visually using a magnifier with 4-fold magnification to examine the upper side of the skin.…”
Section: Methodsmentioning
confidence: 90%
“…We demonstrated in our team’s earlier work [ 47 ] that the freezing process has no impact on the skin’s barrier properties; therefore, the use of frozen–thawed samples of the biological material did not affect the results of this research. The integrity of the skin samples’ barrier was confirmed visually using a magnifier with 4-fold magnification to examine the upper side of the skin.…”
Section: Methodsmentioning
confidence: 90%
“…In recent years, drug delivery of therapeutic agents has been revolutionized by encapsulating them into nanosized vesicular carrier systems. 1,2 These smart systems were reported very effective allowing to overcome limitations and problems associated with conventional drug delivery systems, 3,4 increasing attracting much attention among scientists worldwide. 5 Transdermal route is widely used to deliver chemical drugs and natural compounds to treat skin conditions (e.g., skin diseases, premature aging), because of its numerous advantages over oral (per os) route including, avoidance of first pass effects, decreased fluctuation in drug plasma level, (local) targeted delivery leading to lower side effects and increase efficiency, increased patient compliance.…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, drug delivery of therapeutic agents has been revolutionized by encapsulating them into nanosized vesicular carrier systems 1,2 . These smart systems were reported very effective allowing to overcome limitations and problems associated with conventional drug delivery systems, 3,4 increasing attracting much attention among scientists worldwide 5 …”
Section: Introductionmentioning
confidence: 99%